HBV-CARE Networking Day Report.docx
A systematic report of the HBV-CARE (Clinicians, Advocates and Researchers Exchange) group networking day held at The Francis Crick Institute.
Marion Delphin (11921561) +2 more
core +1 more source
Soroprevalência de marcadores da infecção pelo HBV e dos títulos de anti-HBs em indivíduos soropositivos para o HIV [PDF]
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências de Saúde, Programa de Pós-Graduação em Farmácia, Florianópolis, 2014.As infecções pelo HIV e pelo HBV são preocupantes problemas de saúde pública, sendo que, a infecção ...
Martins, Saulo
core
Impact of HBcrAg levels on HBsAg seroconversion after HBV rebound: a case report
Background Nucleoside analogues (NAs) such as entecavir are required for at least 12 months when patients with resolved hepatitis B virus (HBV) infection develop HBV reactivation.
Maki Ohkubo +3 more
doaj +1 more source
Objectives: To unravel the still unexplored HBV-replicative kinetics in anti-HBc-positive/HBsAg-negative people-with-HIV (PWH) suspending tenofovir disoproxil-fumarate/tenofovir-alafenamide (TDF/TAF).
Romina Salpini +16 more
doaj +1 more source
The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: A longitudinal analysis [PDF]
Background/Aims: Although there have been a few reports regarding the effect of basal core promoter (BCP) double mutations (A1762T and G1764A) on hepatitis B viral loads, the association remains uncertain.
Fang, Kong-Xiong +17 more
core +1 more source
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
Tracking the source of the hepatitis B virus-specific CD8 T cells during lamivudine treatment [PDF]
Lamivudine treatment in chronic hepatitis B leads to the reconstitution of virus-specific T cells in the circulation, but it is not clear whether this is the preferential result of T cell efflux from the liver or lymph nodes.
Gotto, J +8 more
core
The risky body mass index ranges for significant hepatitis B viral load: A campus-based study
Significant hepatitis B viral load (>= 10,000 copies/mL) was established to increase risk of advanced liver diseases. The aim of this study was to explore the metabolic risk factors for significant hepatitis B viral load.
Chiang, Chien-Hsieh;Lai, Jin-Shin;Sheu, Jin-Chuan;Yen, Lee-Lan;Liu, Chun-Jen;Huang, Kuo-Chin +1 more
core +1 more source
Decoding sequence recognition code of nucleic acid‐binding proteins of human‐infecting DNA viruses
Human‐infecting DNA viruses remain major health threats, yet the DNA‐recognition mechanisms of their nucleic acid‐binding proteins (NBPs) are poorly understood. Here, we systematically profiled 103 viral NBPs from human‐infecting DNA viruses, with three NBPs from non‐human‐infecting DNA viruses as controls, using high‐throughput screening.
Meifang Tang +10 more
wiley +1 more source
Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery
Hepatitis B virus (HBV), which was discovered in 1965, is a threat to global public health. HBV infects human hepatocytes and leads to acute and chronic liver diseases, and there is no cure.
Kaitao Zhao, Andrew Liu, Yuchen Xia
doaj +1 more source

